KARACHI — Macter International Limited announced on Thursday that it has obtained the required licenses for its Pre-Filled Syringe (PFS) and Pre-Filled Pen (PFP) manufacturing facilities within its biotech area, according to a notice submitted to the Pakistan Stock Exchange (PSX).
The company stated that it now has the capability to manufacture all three injectable biotechnology dosage forms, including vials, PFS, and PFPs.
The notice added that this development will allow Macter to introduce advanced biotechnological products designed to provide enhanced therapeutic benefits and patient convenience.
Macter International was incorporated as a private limited company in Pakistan in 1992 and converted into a public limited company in 2011. The company is engaged in the manufacturing and marketing of pharmaceutical products.
